Table 3.
Parameters | C (n = 14) | C-R (n = 14) | DM (n = 16) | DM-R (n = 16) |
---|---|---|---|---|
FS (%) | 54.1 ± 5.2 | 52.5 ± 2.87 | 48.7 ± 3.4* | 52.6 ± 4.2§ |
PWSV (mm/s) | 44.5 ± 4.6 | 44.3 ± 3.54 | 35.5 ± 5.4* | 42.7 ± 4.6§ |
E (cm/s) | 74.1 ± 11.7 | 66.6 ± 10.2 | 75.1 ± 14.3 | 79.8 ± 12.2# |
A (cm/s) | 52.9 ± 11.3 | 45.5 ± 8.82 | 48.1 ± 18.1 | 63.1 ± 21.8#§ |
E/A | 1.43 ± 0.23 | 1.51 ± 0.31 | 1.77 ± 0.82 | 1.36 ± 0.34§ |
Data are expressed as mean ± standard deviation. One-way ANOVA in a factorial design 2 × 2 and Tukey’s post hoc test.
C untreated rats, C-R rutin-treated rats, DM untreated diabetic rats, DM-R rutin-treated diabetic rats, FS endocardial fractional shortening, PWSV posterior wall shortening velocity, E early diastolic mitral inflow velocity, A late diastolic mitral inflow velocity, E/A E/A ratio.
* p < 0.05 vs C; #p < 0.05 vs C-R; §p < 0.05 vs DM.